Seeking Alpha
Value, growth, long-term horizon, medium-term horizon
Profile| Send Message| ()  

Do you like investing in a stock's momentum trends? If so, we ran a screen you may be interested in.

We began by screening for high-growth stocks, with 5-year projected EPS growth above 20%. We then screened for those with strong upward momentum, rallying above their 20-day, 50-day and 200-day moving averages.

Finally, for a look at company fundamentals, we checked these companies' sales trends to find those with encouraging signs relative to inventory: Increases in revenue outpacing changes in inventory year-over-year, as well as inventory comprising a smaller portion of current assets over the same time period.

Because inventory represents goods not yet sold, faster growth in revenue than inventory is considered a positive signal. Also, since inventory is the least liquid (least easily sellable) part of current assets, the smaller the portion it represents, the better the liquidity.

Interactive Chart: Press Play to compare changes in market cap over the last two years for the top six stocks mentioned below. Analyst ratings sourced from Zacks Investment Research.

Do you think these companies will continue rallying higher? Use this list as a starting point for your own analysis.

List sorted by difference between growth in revenue and inventory.

1. Anika Therapeutics Inc. (ANIK): Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. Market cap at $188.78M. Price at $14.60. Five-year projected EPS growth at 30.00%. The stock is currently rallying 14.25% above its 20-day moving average, 25.34% above its 50-day MA, and 75.89% above its 200-day MA. Revenue grew by 25.27% during the most recent quarter ($18.44M vs. $14.72M y/y). Inventory grew by -18.44% during the same time period ($7.3M vs. $8.95M y/y). Inventory, as a percentage of current assets, decreased from 15.89% to 11.38% during the most recent quarter (comparing three months ending 2011-12-31 to 3 months ending 2010-12-31).

2. ZOLL Medical Corp. (ZOLL): Develops, manufactures and markets resuscitation devices and related software solutions worldwide. Market cap at $2.07B. Price at $92.88. Five-year projected EPS growth at 36.67%. The stock is currently rallying 0.12% above its 20-day moving average, 14.20% above its 50-day MA, and 63.08% above its 200-day MA. Revenue grew by 18.2% during the most recent quarter ($133.75M vs. $113.16M y/y). Inventory grew by -19.84% during the same time period ($56.67M vs. $70.7M y/y). Inventory, as a percentage of current assets, decreased from 26.89% to 21.57% during the most recent quarter (comparing 13 weeks ending 2012-01-01 to 13 weeks ending 2011-01-02).

3. BioScrip Inc. (BIOS): Provides pharmacy and home health services in the United States. Market cap at $380.86M. Price at $6.99. Five-year projected EPS growth at 22.50%. The stock is currently rallying 3.28% above its 20-day moving average, 5.87% above its 50-day MA and 13.20% above its 200-day MA. Revenue grew by 7.31% during the most recent quarter ($483.3M vs. $450.37M y/y). Inventory grew by -14.69% during the same time period ($56.74M vs. $66.51M y/y). Inventory, as a percentage of current assets, decreased from 24.02% to 19.4% during the most recent quarter (comparing three months ending 2011-12-31 to three months ending 2010-12-31).

4. Ulta Salon, Cosmetics & Fragrance, Inc. (ULTA): Provides prestige, mass and salon products and salon services in the United States. Market cap at $5.85B. Price at $94.74. Five-year projected EPS growth at 26.79%. The stock is currently rallying 2.18% above its 20-day moving average, 8.95% above its 50-day MA, and 32.54% above its 200-day MA. Revenue grew by 22.98% during the most recent quarter ($582.51M vs. $473.66M y/y). Inventory grew by 11.96% during the same time period ($244.65M vs. $218.52M y/y). Inventory, as a percentage of current assets, decreased from 54.04% to 42.16% during the most recent quarter (comparing 13 weeks ending 2012-01-28 to 13 weeks ending 2011-01-29).

5. STAAR Surgical Company (STAA): Designs, develops, manufactures and sells implantable lenses for the cataracts and refractive surgery. Market cap at $397.23M. Price at $11.09. Five-year projected EPS growth at 50.00%. The stock is currently rallying 2.56% above its 20-day moving average, 3.69% above its 50-day MA, and 24.25% above its 200-day MA. Revenue grew by 13.83% during the most recent quarter ($16.38M vs. $14.39M y/y). Inventory grew by 3.7% during the same time period ($10.93M vs. $10.54M y/y). Inventory, as a percentage of current assets, decreased from 35.15% to 28.28% during the most recent quarter (comparing three months ending 2011-12-30 to 3 months ending 2010-12-31).

6. CompanhiaBrasileira de Distribuicao (CBD): Operates as a retailer of food products, clothing, home appliances and other products through its chain of hypermarkets, supermarkets, specialized and department stores, convenience stores and the Internet in Brazil. Market cap at $12.27B. Price at $49.36. Five-year projected EPS growth at 30.47%. The stock is currently rallying 3.97% above its 20-day moving average, 6.56% above its 50-day MA, and 22.80% above its 200-day MA. Revenue grew by 21.18% during the most recent quarter ($13,371M vs. $11,034M y/y). Inventory grew by 15.11% during the same time period ($5,553M vs. $4,824M y/y). Inventory, as a percentage of current assets, decreased from 32.88% to 32.14% during the most recent quarter (comparing three months ending 2011-12-31 to 3 months ending 2010-12-31).

*Accounting data sourced from Google Finance, all other data sourced from Finviz.

Source: 6 Rallying High-Growth Stocks With Encouraging Inventory Trends